258 related articles for article (PubMed ID: 16780491)
21. A case of tuberous sclerosis with a giant angiofibroma.
Wataya-Kaneda M; Yano K; Hosokawa K; Yoshikawa K
J Dermatol; 1997 Feb; 24(2):132-4. PubMed ID: 9065711
[TBL] [Abstract][Full Text] [Related]
22. [Multiple unilateral facial angiofibromas: description of a new case].
Bordel-Gómez MT; Monteagudo-Sánchez B; Alvarez-Fernández JC
Actas Dermosifiliogr; 2008 Dec; 99(10):824-7. PubMed ID: 19091228
[No Abstract] [Full Text] [Related]
23. Segmental tuberous sclerosis in a patient presenting as unilateral facial angiofibromas, periungual fibromas and Shagreen patch.
Sener S; Sasmaz S
Eur Rev Med Pharmacol Sci; 2011 Aug; 15(8):980-2. PubMed ID: 21845812
[TBL] [Abstract][Full Text] [Related]
24. Dermacase. Tuberous sclerosis (Bourneville's disease).
Adams SP
Can Fam Physician; 1998 Jun; 44():1251, 1257. PubMed ID: 9640517
[No Abstract] [Full Text] [Related]
25. Tuberous Sclerosis with Severe Cutaneous Manifestation and Multiples Facial Angiofibromas.
Garcia NG; de Carli ML; Oliveira DT; Soares CT; Ribeiro Júnior NV; Sperandio FF; Hanemann JA
Head Neck Pathol; 2016 Dec; 10(4):542-546. PubMed ID: 27140177
[TBL] [Abstract][Full Text] [Related]
26. Treatment of the facial angiofibromas of tuberous sclerosis.
Verheyden CN
Plast Reconstr Surg; 1996 Oct; 98(5):777-83. PubMed ID: 8823013
[TBL] [Abstract][Full Text] [Related]
27. Facial angiofibromas in a mosaic pattern tuberous sclerosis: A case report.
Alshaiji JM; Spock CR; Connelly EA; Schachner LA
Dermatol Online J; 2012 Jul; 18(7):8. PubMed ID: 22863630
[TBL] [Abstract][Full Text] [Related]
28. Giant angiofibromas in tuberous sclerosis complex: a possible role for localized lymphedema in their pathogenesis.
Kacerovska D; Kerl K; Michal M; Filipova H; Vrtel R; Vanecek T; Zelenakova H; Kraus J; Kodet R; Kazakov DV
J Am Acad Dermatol; 2012 Dec; 67(6):1319-26. PubMed ID: 22552000
[TBL] [Abstract][Full Text] [Related]
29. Oral manifestations leading to the diagnosis of familial tuberous sclerosis.
Martelli H; Lima LS; Bonan PR; Coletta RD
Indian J Dent Res; 2010; 21(1):138-40. PubMed ID: 20427926
[TBL] [Abstract][Full Text] [Related]
30. Images in clinical medicine. Facial angiofibromas associated with tuberous sclerosis.
Hamilton HK; Tonkovic-Capin V
N Engl J Med; 2011 Mar; 364(11):1061. PubMed ID: 21410374
[No Abstract] [Full Text] [Related]
31. Analysis of current data on the use of topical rapamycin in the treatment of facial angiofibromas in tuberous sclerosis complex.
Balestri R; Neri I; Patrizi A; Angileri L; Ricci L; Magnano M
J Eur Acad Dermatol Venereol; 2015 Jan; 29(1):14-20. PubMed ID: 25174683
[TBL] [Abstract][Full Text] [Related]
32. Natural history of a fibrous cephalic plaque and sustained eight decade follow-up in an 80 year old with tuberous sclerosis complex type 2.
Kirk CW; Donnelly DE; Hardy R; Shepherd CW; Morrison PJ
Ulster Med J; 2020 Jan; 89(1):14-16. PubMed ID: 32218621
[TBL] [Abstract][Full Text] [Related]
33. [Multiple tumors of the facial skin].
Kottler UB; Trojan HJ; Holbach LM
Ophthalmologe; 2003 Apr; 100(4):338-9. PubMed ID: 12723576
[No Abstract] [Full Text] [Related]
34. Efficacy and Safety of Topical Rapamycin in Patients With Facial Angiofibromas Secondary to Tuberous Sclerosis Complex: The TREATMENT Randomized Clinical Trial.
Koenig MK; Bell CS; Hebert AA; Roberson J; Samuels JA; Slopis JM; Tate P; Northrup H;
JAMA Dermatol; 2018 Jul; 154(7):773-780. PubMed ID: 29800048
[TBL] [Abstract][Full Text] [Related]
35. Numerous fibrous papules of the face unassociated with any genodermatosis.
Elifritz J; Krishnan RS; Donnelly H
Dermatol Online J; 2007 Oct; 13(4):12. PubMed ID: 18319009
[TBL] [Abstract][Full Text] [Related]
36. Retrospective study of rapamycin or rapalog 0·1% cream for facial angiofibromas in tuberous sclerosis complex: evaluation of treatment effectiveness and cost.
Norrenberg S; Masconi M; Karamanou M; Meylan P; Golaz R; Christen-Zaech S
Br J Dermatol; 2018 Jul; 179(1):208-209. PubMed ID: 29380350
[No Abstract] [Full Text] [Related]
37. Sirolimus Gel Treatment vs Placebo for Facial Angiofibromas in Patients With Tuberous Sclerosis Complex: A Randomized Clinical Trial.
Wataya-Kaneda M; Ohno Y; Fujita Y; Yokozeki H; Niizeki H; Ogai M; Fukai K; Nagai H; Yoshida Y; Hamada I; Hio T; Shimizu K; Murota H
JAMA Dermatol; 2018 Jul; 154(7):781-788. PubMed ID: 29800026
[TBL] [Abstract][Full Text] [Related]
38. Multiple facial angiofibromas: a cutaneous manifestation of Birt-Hogg-Dubé syndrome.
Schaffer JV; Gohara MA; McNiff JM; Aasi SZ; Dvoretzky I
J Am Acad Dermatol; 2005 Aug; 53(2 Suppl 1):S108-11. PubMed ID: 16021156
[TBL] [Abstract][Full Text] [Related]
39. Treatment of angiofibromas of tuberous sclerosis with 5-aminolevulinic acid blue light photodynamic therapy followed by immediate pulsed dye laser.
Weinberger CH; Endrizzi B; Hook KP; Lee PK
Dermatol Surg; 2009 Nov; 35(11):1849-51. PubMed ID: 19682000
[No Abstract] [Full Text] [Related]
40. Rapamycin therapy for renal, brain, and skin lesions in a tuberous sclerosis patient.
Micozkadioglu H; Koc Z; Ozelsancak R; Yildiz I
Ren Fail; 2010; 32(10):1233-6. PubMed ID: 20954988
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
